Krs Capital Management, LLC Karuna Therapeutics, Inc. Transaction History

Krs Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$161.01 - $317.85 $72,454 - $143,032	450 Added 23.51%	2,364 $748,000
Q3 2023 Oct 19, 2023	BUY	$164.66 - $218.08 $33,755 - $44,706	205 Added 12.0%	1,914 $323,000
Q2 2023 Jul 14, 2023	BUY	$176.32 - $240.22 $4,408 - $6,005	25 Added 1.48%	1,709 $370,000
Q1 2023 Apr 11, 2023	BUY	$161.33 - $204.36 $271,679 - $344,142	1,684 New	1,684 $305,000
Q1 2022 Apr 27, 2022	SELL	$98.9 - $132.37 $29,670 - $39,711	-300 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$110.64 - $159.4 $33,192 - $47,820	300 New	300 $39,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Krs Capital Management, LLC with notifications on news.